Wheatley Psychopharmacology in Family Practice

1. Auflage 2018
ISBN: 978-1-4831-6419-9
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 216 Seiten, Web PDF

Psychopharmacology in Family Practice discusses the concept of psychopharmacology in the context of family practice. The book is an account of the group of studies done by the author's group regarding the various concerns in psychopharmacology. The text covers the rationale, organization, and methodology. Next, the book deals with the placebo response. The next two chapters discuss the drugs in anxiety and depression, respectively. Chapter Six discusses the alternative ideas for treating anxiety and depression, such as the use of non-psychotropic drugs. Chapter Seven describes the factors that influence response, while Chapter Eight deals with psychosomatic pharmacotherapy. The next two chapters tackle the side-effects and transcultural aspects, respectively. The closing chapter presents the summary of the conclusions of the studies. The book will be of great use to psychiatric researchers and practitioners. It can also benefit psychologists.

Autoren/Hrsg.

Wheatley, David

Inhaltsverzeichnis

1;Front Cover;1
2;Psychopharmacology in Family Practice;3
3;Copyright Page;4
4;Foreword;5
5;Table of Contents;7
6;Introduction;10
7;Chapter One. Rationale;12
7.1;What does the G.P. Treat?;13
7.2;Treatment Requirements;20
7.3;A Guideline for Treatment;21
7.4;Psychopharmacology as a Special Form of Clinical Pharmacology;23
8;Chapter Two. Organization and Methodology;26
8.1;Sample Size;26
8.2;Constitution and Capabilities;28
8.3;Planning Procedures;30
8.4;Trial Designs;32
8.5;Record Forms;34
8.6;Some Practical Considerations;41
8.7;Assessing Results;42
8.8;The Use of Placebos;59
8.9;The Problem of Drop-outs;59
8.10;Presentation of Results;60
8.11;Conclusion;63
9;Chapter Three. Placebo Response;66
9.1;Conflicting Views;66
9.2;Clinical Implications;67
9.3;Trials in Anxiety and Depression;68
9.4;Symptom Response;71
9.5;Combined Therapy;73
9.6;Choice of Standard Drugs;75
9.7;Conclusion;77
10;Chapter Four. Drugs in Anxiety;79
10.1;The Benzodiazepines;79
10.2;Phenothiazines;84
10.3;Other Anti-anxiety Drugs;86
10.4;Drug Insufficiencies;89
10.5;Conclusion;90
11;Chapter Five. Drugs in Depression;93
11.1;Diagnostic Distinctions;93
11.2;The Tricyclics;94
11.3;Mono-amine Oxidase Inhibitors;99
11.4;Combinations;101
11.5;Newer Compounds;104
11.6;Sedatives as Antidepressants;104
11.7;Drug Insufficiencies;109
11.8;Conclusion;110
12;Chapter Six. New Ideas;114
12.1;Anxiety;114
12.2;Depression;116
12.3;Hormonal Potentiation;118
12.4;Conclusion;121
13;Chapter Seven. Factors Influencing Response;123
13.1;Doctors' and Patients' Attitudes;124
13.2;Combining Results from a Number of Trials;129
13.3;Some Patient Variables;131
13.4;Effects of Life Situations;134
13.5;Future Considerations;136
13.6;External Events;139
13.7;Clinical Significance;140
13.8;Conclusions;141
14;Chapter Eight. Psychosomatic Pharmacotherapy;144
14.1;Enuresis;144
14.2;Asthma and Ischaemic Heart Disease;151
14.3;Gastro-intestinal Disorders;154
14.4;Disorders of Female Physiology;158
14.5;Disorders of Sexual Function;162
14.6;Musculo-skeletal Disorders;164
14.7;Insomnia;166
14.8;Arteriosclerotic Mental Illness;171
14.9;Iatrogenic Psychiatric Illness;174
14.10;Conclusions;175
15;Chapter Nine. Side-effects;179
15.1;Placebo Side-effects;180
15.2;Side-effects in Anxiety;183
15.3;Severity of Side-effects in Anxiety;186
15.4;Side-effects in Depression;188
15.5;Severity of Antidepressant Side-effects;191
15.6;Side-effects with Other Drugs;192
15.7;Time Relationship;195
15.8;Practical Aspects;197
15.9;Influence of Side-effects on Dosage;198
15.10;Conclusions;199
16;Chapter Ten. Transcultural Aspects;201
16.1;Other Factors;204
16.2;Drug Abuse and Alcoholism;205
16.3;Conclusions;207
17;Chapter Eleven. Summary of the Conclusions;209
18;Index;212